A New Class of Selective COX-2 Inactivators
J ournal of Medicinal Chemistry, 1998, Vol. 41, No. 24 4817
col. Exp. Ther. 1990, 254, 180-187. (b) Penning, T. D.; Talley,
J . J .; Bertenshaw, S. R.; Carter, J . S.; Collins, P. W.; Docter, S.;
Graneto, M. J .; Lee, l. F.; Malecha, J . W.; Miyashiro, J . M.;
Rogers, R. S.; Rogier, D. J .; Yu, S. S.; Anderson, G. D.; Burton,
E. G.; Nita Cogburn, J .; Gregory, S. A.; Koboldt, C. M.; Perkins,
W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P.
C. Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole
Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-
(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul-
fonamide (SC-58635, Celecoxib). J . Med. Chem. 1997, 40, 1347-
1365. (c) Khanna, I. K.; Weier, R. M.; Yu, Y.; Xu, X. D.; Koszyk,
F. J .; Collins, P. W.; Koboldt, C. M.; Veenhuizen, A. W.; Perkins,
W. E.; Casler, J . J .; Masferrer, J . L.; Zhang, Y. Y.; Gregory, S.
A.; Seibert, K.; Isakson, P. C. 1,2-Diarylimidazoles as Potent
Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory
Agents. J . Med. Chem. 1997, 40, 1634-1647. (d) Khanna, I. K.;
Weier, R. M.; Yu, Y.; Collins, P. W.; Miyashiro, J . M.; Koboldt,
C. M.; Veenhuizen, A. W.; Curie, J . L.; Seibert, K.; Isakson, P.
C. 1,2-Diarylpyrroles as Potent and Selective Inhibitors of
Cyclooxygenase-2. J . Med. Chem. 1997, 40, 1619-1633. (d) Tsuji,
K.; Nakamura, K.; Konishi, N.; Tojo, T.; Ochi, T.; Senoh, H.;
Matsuo, M. Synthesis and Pharmacological Properties of 1,5-
Diarylyrazoles and Related Derivatives. Chem. Pharm. Bull.
1997, 45, 987-995.
(19) (a) Tanaka, K.; Shimotori, T.; Makino, S.; Aikawa, Y.; Inaba,
T.; Yoshida, C.; Takano, S. Pharmacological Studies of the New
Antiinflammatory Agent 3-Formylamino-7-methylsulfonylamino-
6-phenoxy-4H-1-benzopyran-4-one. 1st Communication: Anti-
inflammatory, Analgesic and Other Related Properties. Arzniem.-
Forsch./ Drug Res. 1992, 42, 935-944. (b) Nakamura, K.; Tsuji,
K.; Konishi, N.; Okumura, H.; Matsuo, M. Studies on Anti-
inflammatory Agents. I. Synthesis and Pharmacological Proper-
ties of 2′-(phenylthio)methanesulfonamides and Related Deriva-
tives. Chem. Pharm. Bull. 1993, 41, 894-906.
(20) Chan, C.-C.; Boyce, S.; Brideau, C.; Ford-Hutchinson, A. W.;
Gordon, R.; Guay, D.; Hill, R. G.; Li, C.-S.; Mancini, J .; Penneton,
M.; Prasit, P.; Rasori, R.; Riendeau, D.; Roy, P.; Tagari, P.;
Vickers, P.; Wong, E.; Rodger, I. W. Pharmacology of a Selective
Cyclooxygenase-2 Inhibitor, L-745,337: A Novel Nonsteroidal
Antiinflammatory Agent With a Ulcerogenic Sparing Efect in
Rat and Nonhuman Primate Stomach. J . Pharmacol. Exp. Ther.
1995, 274, 1531-1537.
(21) Kalgutkar, A. S.; Crews, B. C.; Marnett, L. J . Kinetics of the
Interaction of Nonsteroidal Antiinflammatory Drugs with Pros-
taglandin Endoperoxide Synthase-1 Studied by Limited Pro-
teolysis. Biochemistry 1996, 35, 9076-9082.
(22) Copeland, R. A.; Williams, J . M.; Giannaras, J .; Nurnberg, S.;
Covington, M.; Pinto, D.; Pick, S.; Trzaskos, J . M. Mechanism
of Selective Inhibition of the Inducible Isoform of Prostaglandin
G/H Synthase. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11202-
11206.
(15) (a) Riendeau, D.; Percival, M. D.; Boyce, S.; Brideau, C.;
Charleson, S.; Cromlish, W.; Ethier, D.; Evans, J .; Falgueyret,
J .-P.; Ford-Hutchinson, A. W.; Gordon, R.; Greig, G.; Gresser,
M.; Guay, J .; Kargman, S.; Le´ger, S.; Mancini, J . A.; O’Neill, G.;
Quellet, M.; Rodger, I. W.; The´rien, M.; Wang, Z.; Webb, J . K.;
Wong, E.; Xu, L.; Young, R. N.; Zamboni, R.; Prasit, P.; Chan,
C.-C. Biochemical and Pharmacological Profile of a Tetrasub-
stituted Furanone as a Highly Selective COX-2 Inhibitor. Br. J .
Pharmacol. 1997, 121, 105-117. (b) Roy, P.; Leblanc, Y.; Ball,
R. G.; Brideau, C.; Chan, C.-C.; Chauret, N.; Cromlish, W.;
Ethier, D.; Gauthier, J . Y.; Gordon, R.; Greig, G.; Guay, J .;
Kargman, S.; Lau, C. K.; O’Neill, G.; Silva, J .; The´rien, M.; Van
Staden, C.; Wong, E.; Xu, L.; Prasit, P. A New Series of Selective
COX-2 Inhibitors: 5,6-Diarylthiazolo[3,2-b][1,2,4]-triazoles. Bioorg.
Med. Chem. Lett. 1997, 7, 57-62. (c) The´rien, M.; Brideau, C.;
Chan, C.-C.; Cromlish, W. A.; Gauthier, J . Y.; Gordon, R.; Greig,
G.; Kargman, S.; Lau, C. K.; Leblanc, Y.; Li, C.-S. L.; O’Neill, G.
P.; Riendeau, D.; Roy, P.; Wang, Z.; Xu, L.; Prasit, P. Synthesis
and Biological Evaluation of 5,6-Diarylimidazo[2.1-b]thiazoles
as Selective COX-2 Inhibitors. Bioorg. Med. Chem. Lett. 1997,
7, 47-52.
(16) (a) Li, J . J .; Norton, M. B.; Reinhard, E. J .; Anderson, G. D.;
Gregory, S. A.; Isakson, P. C.; Koboldt, C. M.; Masferrer, J . L.;
Perkins, W. E.; Seibert, K.; Zhang, Y.; Zweifel, B. S.; Reitz, D.
B. Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors
and Orally Active Antiinflammatory Agents. J . Med. Chem.
1996, 39, 1846-1856. (b) Li, J . J .; Anderson, G. D.; Burton, E.
G.; Cogburn, J . N.; Collins, J . T.; Garland, D. J .; Gregory, S. A.;
Huang, H.-C.; Isakson, P. C.; Koboldt, C. M.; Logusch, E. W.;
Norton, M. B.; Perkins, W. E.; Reinhard, E. J .; Seibert, K.;
Veenhuizen, A. W.; Zhang, Y.; Reitz, D. B. 1,2-Diarylcyclo-
pentenes as Selective Cyclooxygenase-2 Inhibitors and Orally
Active Antiinflammatory Agents. J . Med. Chem. 1995, 38, 4570-
4578. (c) Reitz, D. B.; Li, J . J .; Norton, M. B.; Reinhard, E. J .;
Huang, H.-C.; Penick, M. A.; Collins, J . T.; Garland, D. J . Novel
1,2-Diarylcyclopentenes are Selective Potent, and Orally Active
Cyclooxygenase Inhibitors. Med. Chem. Res. 1995, 5, 351-363.
(17) (a) Futaki, N.; Yoshikawa, K.; Hamasaka, Y.; Arai, I.; Higuchi,
S.; Iizuka, H.; Otomo, S. NS-398, A Novel Nonsteroidal Anti-
inflammatory Drug With Potent Analgesic and Antipyretic
Effects, Which Causes Minimal Stomach Lesions. Gen. Phar-
macol. 1993, 24, 105-110. (b) Wiesenberg-Boetcher, I.; Schwei-
zer, A.; Green, J . R.; Muller, K.; Maerki, F.; Pfeilschifter, J . The
Pharmacological Profile of CGP 28238, a Novel Highly Potent
Antiinflammatory Compound. Drugs Exp. Clin. Res. 1989, XV,
501-509. (c) Futaki, N.; Takahashi, S.; Yokoyama, M.; Arai, I.;
Higuchi, S.; Otomo, S. NS-398, A New Anti- Inflammatory
Agent, Selectively Inhibits Prostaglandin G/H Synthase/Cy-
clooxygenase (COX-2) Activity In Vitro. Prostaglandins 1994,
47, 55-59. (d) Klein, T.; Nusing, R. M.; Pfeilschifter, J .; Ullrich,
V. Selective Inhibition of Cyclooxygenase-2. Biochem. Pharmacol.
1994, 48, 1605-1610.
(23) (a) Vane, J . R. Inhibition of Prostaglandin Synthesis as
a
Mechanism of Action for Aspirin-Like Drugs. Nature (New Biol.)
1971, 231, 232-234. (b) Smith, J . B.; Willis, A. L. Aspirin
Selectively Inhibits Prostaglandin Production in Human Plate-
lets. Nature (New Biol.) 1971, 232, 235-237. (c) Ferreira, S. H.;
Moncada, S.; Vane, J . R. Indomethacin and Aspirin Abolish
Prostaglandin Release From Spleen. Nature (New Biol.) 1971,
231, 237-239. (d) Smith, W. L.; Lands, W. E. M. Stimulation
and Blockade of Prostaglandin Biosynthesis. J . Biol. Chem.
1971, 246, 6700-6704.
(24) (a) Roth, G. J .; Majerus, P. W. The Mechanism of the Effect of
Aspirin on Platelets. I. Acetylation of a Particular Fraction of
Protein. J . Clin. Invest. 1975, 56, 624-632. (b) Roth, G. J .;
Stanford, N.; Majerus, P. W. Acetylation of Prostaglandin
Synthase by Aspirin. Proc. Natl. Acad. Sci. U.S.A. 1975, 72,
3073-3076. (c) van der Ouderaa, F. J .; Buytenhek, M.; Nugteren,
D. H.; van Dorp, D. A. Acetylation of Prostaglandin Endoper-
oxide Synthetase with Acetylsalicylic Acid. Eur. J . Biochem.
1980, 109, 1-8. (d) Roth, G. J .; Machuga, E. T.; Ozols, J .
Isolation and Covalent Structure of the Aspirin Modified, Active
Site Region of Prostaglandin Synthetase. Biochemistry 1983, 22,
4672-4675.
(25) Lecomte, M.; Laneuville, O.; J i, C.; DeWitt, D. L.; Smith, W. L.
Acetylation of Human Prostaglandin Endoperoxide Synthase-2
(Cyclooxygenase-2) by Aspirin. J . Biol. Chem. 1994, 269, 13207-
13215.
(26) Kalgutkar, A. S.; Crews, B. C.; Rowlinson, S. W.; Garner, C.;
Seibert, K.; Marnett, L. J . Aspirin-Like Molecules That Co-
valently Inactivate Cyclooxygenase-2. Science 1998, 280, 1268-
1270.
(27) Trost, B. M.; Curran, D. P. Chemoselective Oxidation of Sulfides
to Sulfones With Potassium Hydrogen Persulfate. Tetrahedron
Lett. 1981, 22, 1287-1290.
(28) Paradisi, M. G.; Zecchini, G. P.; Torrini, I. Selective Acylations
of Aminophenols and Hydroxyalkylphenols with 1-Acetyl-v-
triazolo-[4,5-b]pyridine. Tetrahedron Lett. 1986, 27, 5029-5032.
(29) Parameswaran, K. N.; Shi, G.-Y.; Klotz, I. M. O-Carbamoyl-
salicylates: Agents for the Modification of Hemoglobins. J . Med.
Chem. 1987, 30, 936-939.
(30) Narasimhan, N. S.; Mali, R. S. Synthesis of Heterocyclic
Compounds Involving Aromatic Lithiations Reactions in the Key
Step. Synthesis 1983, 12, 957-986.
(31) Narasimhan, N. S.; Mali, R. S.; Barve, M. V. Synthetic Applica-
tion of Lithiation Reactions; Part XIII. Synthesis of 3-Phenyl-
coumarins and Their Benzo Derivatives. Synthesis 1979, 8, 906-
909.
(32) Snieckus, V.; Beaulieu, F.; Mohri, K.; Han, W.; Murphy, C. K.;
Davis, F. A. Directed ortho Metalation-mediated F+ Introduc-
tion. Regiospecific Synthesis of Fluorinated Aromatics. Tetra-
hedron Lett. 1994, 35, 3465-3468.
(33) That the lithiation of 86 followed by reaction with methyl
chloroformate afforded 88a and not 88b was confirmed by NOE
experiments: Irradiation of the resonance at δ 2.46 (SCH3) gave
a strong, positive NOE signal at δ 7.38 which is consistent with
the presence of an aromatic proton (Ha) in spatial proximity to
the SCH3 moiety (not possible in 88b); a relatively weak NOE
signal also was observed at δ 11.38 which is consistent with the
presence of a phenolic OH group in proximity to the SCH3
moiety. Irradiation of the resonance at δ 3.96 (CO2CH3) afforded
(18) (a) Li, C.-S.; Black, W. C.; Chan, C.-C.; Ford-Hutchinson, A. W.;
Gauthier, J .-Y.; Gordon, R.; Guay, D.; Kargman, S.; Lau, C. K.;
Mancini, J .; Quimet, N.; Roy, P.; Vickers, P.; Wong, E.; Young,
R. N.; Zamboni, R.; Prasit, P. Cyclooxygenase-2 Inhibitors.
Synthesis and Pharmacological Activities of 5-Methanesulfon-
amido-1-indanone Derivatives. J . Med. Chem. 1995, 38, 4897-
4905. (b) Prasit, P.; Black, W. C.; Chan, C.-C.; Ford-Hutchinson,
A. W.; Gauthier, J .-Y.; Gordon, R.; Guay, D.; Kargman, S.; Lau,
C. K.; Li, C.-S.; Mancini, J .; Quimet, N.; Roy, P.; Tagari, P.;
Vickers, P.; Wong, E.; Young, R. N.; Zamboni, R. L-745,337: A
Selective Cyclooxygenase-2 Inhibitor. Med. Chem. Res. 1995, 5,
364-374.